nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—GNRHR—gonad—ovarian cancer	0.00563	0.292	CbGeAlD
Degarelix—GNRHR—female reproductive system—ovarian cancer	0.00503	0.261	CbGeAlD
Degarelix—GNRHR—female gonad—ovarian cancer	0.00458	0.237	CbGeAlD
Degarelix—GNRHR—testis—ovarian cancer	0.00406	0.21	CbGeAlD
Degarelix—Cardiac failure—Epirubicin—ovarian cancer	0.0015	0.00153	CcSEcCtD
Degarelix—Diarrhoea—Topotecan—ovarian cancer	0.00149	0.00152	CcSEcCtD
Degarelix—Hypoaesthesia—Docetaxel—ovarian cancer	0.00149	0.00152	CcSEcCtD
Degarelix—Back pain—Paclitaxel—ovarian cancer	0.00149	0.00152	CcSEcCtD
Degarelix—Urticaria—Vinorelbine—ovarian cancer	0.00148	0.00151	CcSEcCtD
Degarelix—Urinary tract disorder—Docetaxel—ovarian cancer	0.00148	0.00151	CcSEcCtD
Degarelix—Muscle spasms—Paclitaxel—ovarian cancer	0.00148	0.00151	CcSEcCtD
Degarelix—Body temperature increased—Vinorelbine—ovarian cancer	0.00148	0.00151	CcSEcCtD
Degarelix—Abdominal pain—Vinorelbine—ovarian cancer	0.00148	0.00151	CcSEcCtD
Degarelix—Oedema peripheral—Docetaxel—ovarian cancer	0.00148	0.00151	CcSEcCtD
Degarelix—Urethral disorder—Docetaxel—ovarian cancer	0.00147	0.0015	CcSEcCtD
Degarelix—Diarrhoea—Melphalan—ovarian cancer	0.00146	0.00149	CcSEcCtD
Degarelix—Nausea—Chlorambucil—ovarian cancer	0.00146	0.00149	CcSEcCtD
Degarelix—Vision blurred—Paclitaxel—ovarian cancer	0.00145	0.00148	CcSEcCtD
Degarelix—Hot flush—Doxorubicin—ovarian cancer	0.00145	0.00147	CcSEcCtD
Degarelix—Dizziness—Topotecan—ovarian cancer	0.00144	0.00147	CcSEcCtD
Degarelix—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00143	0.00146	CcSEcCtD
Degarelix—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00143	0.00146	CcSEcCtD
Degarelix—Anaemia—Paclitaxel—ovarian cancer	0.00142	0.00145	CcSEcCtD
Degarelix—Renal impairment—Doxorubicin—ovarian cancer	0.00142	0.00145	CcSEcCtD
Degarelix—Eye disorder—Docetaxel—ovarian cancer	0.0014	0.00143	CcSEcCtD
Degarelix—Cardiac disorder—Docetaxel—ovarian cancer	0.00139	0.00142	CcSEcCtD
Degarelix—Vomiting—Topotecan—ovarian cancer	0.00139	0.00142	CcSEcCtD
Degarelix—Malaise—Paclitaxel—ovarian cancer	0.00139	0.00142	CcSEcCtD
Degarelix—Cardiac failure—Doxorubicin—ovarian cancer	0.00139	0.00141	CcSEcCtD
Degarelix—Rash—Topotecan—ovarian cancer	0.00138	0.0014	CcSEcCtD
Degarelix—Hypersensitivity—Vinorelbine—ovarian cancer	0.00138	0.0014	CcSEcCtD
Degarelix—Dermatitis—Topotecan—ovarian cancer	0.00138	0.0014	CcSEcCtD
Degarelix—Headache—Topotecan—ovarian cancer	0.00137	0.00139	CcSEcCtD
Degarelix—Palpitations—Paclitaxel—ovarian cancer	0.00136	0.00139	CcSEcCtD
Degarelix—Angiopathy—Docetaxel—ovarian cancer	0.00136	0.00139	CcSEcCtD
Degarelix—Vomiting—Melphalan—ovarian cancer	0.00136	0.00139	CcSEcCtD
Degarelix—Immune system disorder—Docetaxel—ovarian cancer	0.00135	0.00138	CcSEcCtD
Degarelix—Mediastinal disorder—Docetaxel—ovarian cancer	0.00135	0.00138	CcSEcCtD
Degarelix—Rash—Melphalan—ovarian cancer	0.00135	0.00137	CcSEcCtD
Degarelix—Dermatitis—Melphalan—ovarian cancer	0.00135	0.00137	CcSEcCtD
Degarelix—Chills—Docetaxel—ovarian cancer	0.00134	0.00137	CcSEcCtD
Degarelix—Asthenia—Vinorelbine—ovarian cancer	0.00134	0.00137	CcSEcCtD
Degarelix—Arrhythmia—Docetaxel—ovarian cancer	0.00134	0.00137	CcSEcCtD
Degarelix—Hypertension—Paclitaxel—ovarian cancer	0.00133	0.00136	CcSEcCtD
Degarelix—Alopecia—Docetaxel—ovarian cancer	0.00132	0.00135	CcSEcCtD
Degarelix—Pruritus—Vinorelbine—ovarian cancer	0.00132	0.00135	CcSEcCtD
Degarelix—Breast disorder—Epirubicin—ovarian cancer	0.00132	0.00135	CcSEcCtD
Degarelix—Mental disorder—Docetaxel—ovarian cancer	0.00131	0.00134	CcSEcCtD
Degarelix—Arthralgia—Paclitaxel—ovarian cancer	0.00131	0.00134	CcSEcCtD
Degarelix—Malnutrition—Docetaxel—ovarian cancer	0.0013	0.00133	CcSEcCtD
Degarelix—Erythema—Docetaxel—ovarian cancer	0.0013	0.00133	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.0013	0.00133	CcSEcCtD
Degarelix—Nausea—Topotecan—ovarian cancer	0.0013	0.00132	CcSEcCtD
Degarelix—Discomfort—Paclitaxel—ovarian cancer	0.00129	0.00132	CcSEcCtD
Degarelix—Muscular weakness—Epirubicin—ovarian cancer	0.00129	0.00131	CcSEcCtD
Degarelix—Dry mouth—Paclitaxel—ovarian cancer	0.00128	0.00131	CcSEcCtD
Degarelix—Diarrhoea—Vinorelbine—ovarian cancer	0.00128	0.0013	CcSEcCtD
Degarelix—Nausea—Melphalan—ovarian cancer	0.00127	0.00129	CcSEcCtD
Degarelix—Back pain—Docetaxel—ovarian cancer	0.00126	0.00129	CcSEcCtD
Degarelix—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00126	0.00128	CcSEcCtD
Degarelix—Muscle spasms—Docetaxel—ovarian cancer	0.00125	0.00128	CcSEcCtD
Degarelix—Dizziness—Vinorelbine—ovarian cancer	0.00124	0.00126	CcSEcCtD
Degarelix—Nervous system disorder—Paclitaxel—ovarian cancer	0.00123	0.00126	CcSEcCtD
Degarelix—Breast disorder—Doxorubicin—ovarian cancer	0.00122	0.00125	CcSEcCtD
Degarelix—Skin disorder—Paclitaxel—ovarian cancer	0.00122	0.00124	CcSEcCtD
Degarelix—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00121	0.00124	CcSEcCtD
Degarelix—Anaemia—Docetaxel—ovarian cancer	0.00121	0.00123	CcSEcCtD
Degarelix—Muscular weakness—Doxorubicin—ovarian cancer	0.00119	0.00122	CcSEcCtD
Degarelix—Vomiting—Vinorelbine—ovarian cancer	0.00119	0.00121	CcSEcCtD
Degarelix—Dysuria—Epirubicin—ovarian cancer	0.00118	0.0012	CcSEcCtD
Degarelix—Rash—Vinorelbine—ovarian cancer	0.00118	0.0012	CcSEcCtD
Degarelix—Dermatitis—Vinorelbine—ovarian cancer	0.00118	0.0012	CcSEcCtD
Degarelix—Hypotension—Paclitaxel—ovarian cancer	0.00117	0.0012	CcSEcCtD
Degarelix—Headache—Vinorelbine—ovarian cancer	0.00117	0.00119	CcSEcCtD
Degarelix—Pollakiuria—Epirubicin—ovarian cancer	0.00117	0.00119	CcSEcCtD
Degarelix—Palpitations—Docetaxel—ovarian cancer	0.00115	0.00118	CcSEcCtD
Degarelix—Weight increased—Epirubicin—ovarian cancer	0.00115	0.00117	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00114	0.00117	CcSEcCtD
Degarelix—Weight decreased—Epirubicin—ovarian cancer	0.00114	0.00117	CcSEcCtD
Degarelix—Hyperglycaemia—Epirubicin—ovarian cancer	0.00114	0.00116	CcSEcCtD
Degarelix—Insomnia—Paclitaxel—ovarian cancer	0.00114	0.00116	CcSEcCtD
Degarelix—Hypertension—Docetaxel—ovarian cancer	0.00113	0.00115	CcSEcCtD
Degarelix—Dyspnoea—Paclitaxel—ovarian cancer	0.00112	0.00114	CcSEcCtD
Degarelix—Arthralgia—Docetaxel—ovarian cancer	0.00111	0.00113	CcSEcCtD
Degarelix—Nausea—Vinorelbine—ovarian cancer	0.00111	0.00113	CcSEcCtD
Degarelix—Renal failure—Epirubicin—ovarian cancer	0.00111	0.00113	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.0011	0.00112	CcSEcCtD
Degarelix—Urinary tract infection—Epirubicin—ovarian cancer	0.00109	0.00112	CcSEcCtD
Degarelix—Dysuria—Doxorubicin—ovarian cancer	0.00109	0.00111	CcSEcCtD
Degarelix—Decreased appetite—Paclitaxel—ovarian cancer	0.00109	0.00111	CcSEcCtD
Degarelix—Dry mouth—Docetaxel—ovarian cancer	0.00109	0.00111	CcSEcCtD
Degarelix—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00108	0.00111	CcSEcCtD
Degarelix—Fatigue—Paclitaxel—ovarian cancer	0.00108	0.0011	CcSEcCtD
Degarelix—Pollakiuria—Doxorubicin—ovarian cancer	0.00108	0.0011	CcSEcCtD
Degarelix—Constipation—Paclitaxel—ovarian cancer	0.00107	0.0011	CcSEcCtD
Degarelix—Pain—Paclitaxel—ovarian cancer	0.00107	0.0011	CcSEcCtD
Degarelix—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00107	0.00109	CcSEcCtD
Degarelix—Anaphylactic shock—Docetaxel—ovarian cancer	0.00106	0.00109	CcSEcCtD
Degarelix—Weight increased—Doxorubicin—ovarian cancer	0.00106	0.00108	CcSEcCtD
Degarelix—Weight decreased—Doxorubicin—ovarian cancer	0.00106	0.00108	CcSEcCtD
Degarelix—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00105	0.00107	CcSEcCtD
Degarelix—Nervous system disorder—Docetaxel—ovarian cancer	0.00104	0.00106	CcSEcCtD
Degarelix—Feeling abnormal—Paclitaxel—ovarian cancer	0.00104	0.00106	CcSEcCtD
Degarelix—Skin disorder—Docetaxel—ovarian cancer	0.00103	0.00105	CcSEcCtD
Degarelix—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00103	0.00105	CcSEcCtD
Degarelix—Renal failure—Doxorubicin—ovarian cancer	0.00102	0.00104	CcSEcCtD
Degarelix—Urinary tract infection—Doxorubicin—ovarian cancer	0.00101	0.00103	CcSEcCtD
Degarelix—Hypoaesthesia—Epirubicin—ovarian cancer	0.00101	0.00103	CcSEcCtD
Degarelix—Urinary tract disorder—Epirubicin—ovarian cancer	0.000998	0.00102	CcSEcCtD
Degarelix—Urticaria—Paclitaxel—ovarian cancer	0.000998	0.00102	CcSEcCtD
Degarelix—Oedema peripheral—Epirubicin—ovarian cancer	0.000996	0.00102	CcSEcCtD
Degarelix—Hypotension—Docetaxel—ovarian cancer	0.000995	0.00101	CcSEcCtD
Degarelix—Body temperature increased—Paclitaxel—ovarian cancer	0.000993	0.00101	CcSEcCtD
Degarelix—Abdominal pain—Paclitaxel—ovarian cancer	0.000993	0.00101	CcSEcCtD
Degarelix—Urethral disorder—Epirubicin—ovarian cancer	0.000991	0.00101	CcSEcCtD
Degarelix—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000986	0.001	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00097	0.000989	CcSEcCtD
Degarelix—Insomnia—Docetaxel—ovarian cancer	0.000963	0.000982	CcSEcCtD
Degarelix—Dyspnoea—Docetaxel—ovarian cancer	0.000949	0.000968	CcSEcCtD
Degarelix—Eye disorder—Epirubicin—ovarian cancer	0.000945	0.000963	CcSEcCtD
Degarelix—Cardiac disorder—Epirubicin—ovarian cancer	0.000938	0.000957	CcSEcCtD
Degarelix—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000931	0.000949	CcSEcCtD
Degarelix—Decreased appetite—Docetaxel—ovarian cancer	0.000926	0.000944	CcSEcCtD
Degarelix—Hypersensitivity—Paclitaxel—ovarian cancer	0.000926	0.000944	CcSEcCtD
Degarelix—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000924	0.000942	CcSEcCtD
Degarelix—Oedema peripheral—Doxorubicin—ovarian cancer	0.000922	0.00094	CcSEcCtD
Degarelix—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000919	0.000937	CcSEcCtD
Degarelix—Fatigue—Docetaxel—ovarian cancer	0.000918	0.000936	CcSEcCtD
Degarelix—Angiopathy—Epirubicin—ovarian cancer	0.000917	0.000935	CcSEcCtD
Degarelix—Urethral disorder—Doxorubicin—ovarian cancer	0.000917	0.000935	CcSEcCtD
Degarelix—Immune system disorder—Epirubicin—ovarian cancer	0.000913	0.000931	CcSEcCtD
Degarelix—Mediastinal disorder—Epirubicin—ovarian cancer	0.000911	0.000929	CcSEcCtD
Degarelix—Pain—Docetaxel—ovarian cancer	0.000911	0.000929	CcSEcCtD
Degarelix—Constipation—Docetaxel—ovarian cancer	0.000911	0.000929	CcSEcCtD
Degarelix—Chills—Epirubicin—ovarian cancer	0.000907	0.000925	CcSEcCtD
Degarelix—Arrhythmia—Epirubicin—ovarian cancer	0.000903	0.000921	CcSEcCtD
Degarelix—Asthenia—Paclitaxel—ovarian cancer	0.000901	0.000919	CcSEcCtD
Degarelix—Alopecia—Epirubicin—ovarian cancer	0.000893	0.000911	CcSEcCtD
Degarelix—Pruritus—Paclitaxel—ovarian cancer	0.000889	0.000906	CcSEcCtD
Degarelix—Mental disorder—Epirubicin—ovarian cancer	0.000886	0.000903	CcSEcCtD
Degarelix—Malnutrition—Epirubicin—ovarian cancer	0.00088	0.000897	CcSEcCtD
Degarelix—Erythema—Epirubicin—ovarian cancer	0.00088	0.000897	CcSEcCtD
Degarelix—Feeling abnormal—Docetaxel—ovarian cancer	0.000878	0.000895	CcSEcCtD
Degarelix—Eye disorder—Doxorubicin—ovarian cancer	0.000874	0.000891	CcSEcCtD
Degarelix—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000871	0.000888	CcSEcCtD
Degarelix—Cardiac disorder—Doxorubicin—ovarian cancer	0.000868	0.000885	CcSEcCtD
Degarelix—Diarrhoea—Paclitaxel—ovarian cancer	0.00086	0.000877	CcSEcCtD
Degarelix—Back pain—Epirubicin—ovarian cancer	0.000851	0.000868	CcSEcCtD
Degarelix—Angiopathy—Doxorubicin—ovarian cancer	0.000849	0.000865	CcSEcCtD
Degarelix—Muscle spasms—Epirubicin—ovarian cancer	0.000846	0.000863	CcSEcCtD
Degarelix—Immune system disorder—Doxorubicin—ovarian cancer	0.000845	0.000862	CcSEcCtD
Degarelix—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000843	0.00086	CcSEcCtD
Degarelix—Body temperature increased—Docetaxel—ovarian cancer	0.000842	0.000858	CcSEcCtD
Degarelix—Abdominal pain—Docetaxel—ovarian cancer	0.000842	0.000858	CcSEcCtD
Degarelix—Chills—Doxorubicin—ovarian cancer	0.000839	0.000856	CcSEcCtD
Degarelix—Arrhythmia—Doxorubicin—ovarian cancer	0.000836	0.000852	CcSEcCtD
Degarelix—Dizziness—Paclitaxel—ovarian cancer	0.000831	0.000847	CcSEcCtD
Degarelix—Vision blurred—Epirubicin—ovarian cancer	0.000829	0.000846	CcSEcCtD
Degarelix—Alopecia—Doxorubicin—ovarian cancer	0.000827	0.000843	CcSEcCtD
Degarelix—Mental disorder—Doxorubicin—ovarian cancer	0.00082	0.000836	CcSEcCtD
Degarelix—Ill-defined disorder—Epirubicin—ovarian cancer	0.000817	0.000833	CcSEcCtD
Degarelix—Erythema—Doxorubicin—ovarian cancer	0.000814	0.00083	CcSEcCtD
Degarelix—Malnutrition—Doxorubicin—ovarian cancer	0.000814	0.00083	CcSEcCtD
Degarelix—Anaemia—Epirubicin—ovarian cancer	0.000813	0.000829	CcSEcCtD
Degarelix—Vomiting—Paclitaxel—ovarian cancer	0.000799	0.000815	CcSEcCtD
Degarelix—Malaise—Epirubicin—ovarian cancer	0.000794	0.000809	CcSEcCtD
Degarelix—Rash—Paclitaxel—ovarian cancer	0.000792	0.000808	CcSEcCtD
Degarelix—Dermatitis—Paclitaxel—ovarian cancer	0.000791	0.000807	CcSEcCtD
Degarelix—Back pain—Doxorubicin—ovarian cancer	0.000788	0.000803	CcSEcCtD
Degarelix—Headache—Paclitaxel—ovarian cancer	0.000787	0.000803	CcSEcCtD
Degarelix—Hypersensitivity—Docetaxel—ovarian cancer	0.000785	0.0008	CcSEcCtD
Degarelix—Muscle spasms—Doxorubicin—ovarian cancer	0.000783	0.000798	CcSEcCtD
Degarelix—Palpitations—Epirubicin—ovarian cancer	0.000778	0.000793	CcSEcCtD
Degarelix—Vision blurred—Doxorubicin—ovarian cancer	0.000767	0.000783	CcSEcCtD
Degarelix—Asthenia—Docetaxel—ovarian cancer	0.000764	0.000779	CcSEcCtD
Degarelix—Hypertension—Epirubicin—ovarian cancer	0.00076	0.000775	CcSEcCtD
Degarelix—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000756	0.00077	CcSEcCtD
Degarelix—Pruritus—Docetaxel—ovarian cancer	0.000753	0.000768	CcSEcCtD
Degarelix—Anaemia—Doxorubicin—ovarian cancer	0.000753	0.000767	CcSEcCtD
Degarelix—Arthralgia—Epirubicin—ovarian cancer	0.000749	0.000764	CcSEcCtD
Degarelix—Nausea—Paclitaxel—ovarian cancer	0.000746	0.000761	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000744	0.000759	CcSEcCtD
Degarelix—Discomfort—Epirubicin—ovarian cancer	0.00074	0.000755	CcSEcCtD
Degarelix—Malaise—Doxorubicin—ovarian cancer	0.000734	0.000749	CcSEcCtD
Degarelix—Dry mouth—Epirubicin—ovarian cancer	0.000733	0.000747	CcSEcCtD
Degarelix—Diarrhoea—Docetaxel—ovarian cancer	0.000729	0.000743	CcSEcCtD
Degarelix—Palpitations—Doxorubicin—ovarian cancer	0.00072	0.000734	CcSEcCtD
Degarelix—Anaphylactic shock—Epirubicin—ovarian cancer	0.000718	0.000732	CcSEcCtD
Degarelix—Nervous system disorder—Epirubicin—ovarian cancer	0.000704	0.000718	CcSEcCtD
Degarelix—Dizziness—Docetaxel—ovarian cancer	0.000704	0.000718	CcSEcCtD
Degarelix—Hypertension—Doxorubicin—ovarian cancer	0.000703	0.000717	CcSEcCtD
Degarelix—Skin disorder—Epirubicin—ovarian cancer	0.000698	0.000711	CcSEcCtD
Degarelix—Hyperhidrosis—Epirubicin—ovarian cancer	0.000694	0.000708	CcSEcCtD
Degarelix—Arthralgia—Doxorubicin—ovarian cancer	0.000693	0.000707	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000688	0.000702	CcSEcCtD
Degarelix—Discomfort—Doxorubicin—ovarian cancer	0.000685	0.000698	CcSEcCtD
Degarelix—Dry mouth—Doxorubicin—ovarian cancer	0.000678	0.000691	CcSEcCtD
Degarelix—Vomiting—Docetaxel—ovarian cancer	0.000677	0.00069	CcSEcCtD
Degarelix—Rash—Docetaxel—ovarian cancer	0.000671	0.000685	CcSEcCtD
Degarelix—Hypotension—Epirubicin—ovarian cancer	0.000671	0.000684	CcSEcCtD
Degarelix—Dermatitis—Docetaxel—ovarian cancer	0.000671	0.000684	CcSEcCtD
Degarelix—Headache—Docetaxel—ovarian cancer	0.000667	0.00068	CcSEcCtD
Degarelix—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000665	0.000678	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000654	0.000667	CcSEcCtD
Degarelix—Nervous system disorder—Doxorubicin—ovarian cancer	0.000652	0.000665	CcSEcCtD
Degarelix—Insomnia—Epirubicin—ovarian cancer	0.00065	0.000662	CcSEcCtD
Degarelix—Skin disorder—Doxorubicin—ovarian cancer	0.000646	0.000658	CcSEcCtD
Degarelix—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000642	0.000655	CcSEcCtD
Degarelix—Dyspnoea—Epirubicin—ovarian cancer	0.00064	0.000653	CcSEcCtD
Degarelix—Nausea—Docetaxel—ovarian cancer	0.000633	0.000645	CcSEcCtD
Degarelix—Decreased appetite—Epirubicin—ovarian cancer	0.000624	0.000637	CcSEcCtD
Degarelix—Hypotension—Doxorubicin—ovarian cancer	0.000621	0.000633	CcSEcCtD
Degarelix—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00062	0.000632	CcSEcCtD
Degarelix—Fatigue—Epirubicin—ovarian cancer	0.000619	0.000631	CcSEcCtD
Degarelix—Constipation—Epirubicin—ovarian cancer	0.000614	0.000626	CcSEcCtD
Degarelix—Pain—Epirubicin—ovarian cancer	0.000614	0.000626	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000605	0.000617	CcSEcCtD
Degarelix—Insomnia—Doxorubicin—ovarian cancer	0.000601	0.000613	CcSEcCtD
Degarelix—Dyspnoea—Doxorubicin—ovarian cancer	0.000593	0.000604	CcSEcCtD
Degarelix—Feeling abnormal—Epirubicin—ovarian cancer	0.000592	0.000604	CcSEcCtD
Degarelix—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000587	0.000599	CcSEcCtD
Degarelix—Decreased appetite—Doxorubicin—ovarian cancer	0.000578	0.000589	CcSEcCtD
Degarelix—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000574	0.000585	CcSEcCtD
Degarelix—Fatigue—Doxorubicin—ovarian cancer	0.000573	0.000584	CcSEcCtD
Degarelix—Urticaria—Epirubicin—ovarian cancer	0.000571	0.000582	CcSEcCtD
Degarelix—Pain—Doxorubicin—ovarian cancer	0.000568	0.00058	CcSEcCtD
Degarelix—Constipation—Doxorubicin—ovarian cancer	0.000568	0.00058	CcSEcCtD
Degarelix—Abdominal pain—Epirubicin—ovarian cancer	0.000568	0.000579	CcSEcCtD
Degarelix—Body temperature increased—Epirubicin—ovarian cancer	0.000568	0.000579	CcSEcCtD
Degarelix—Feeling abnormal—Doxorubicin—ovarian cancer	0.000548	0.000558	CcSEcCtD
Degarelix—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000543	0.000554	CcSEcCtD
Degarelix—Hypersensitivity—Epirubicin—ovarian cancer	0.000529	0.00054	CcSEcCtD
Degarelix—Urticaria—Doxorubicin—ovarian cancer	0.000528	0.000538	CcSEcCtD
Degarelix—Abdominal pain—Doxorubicin—ovarian cancer	0.000525	0.000536	CcSEcCtD
Degarelix—Body temperature increased—Doxorubicin—ovarian cancer	0.000525	0.000536	CcSEcCtD
Degarelix—Asthenia—Epirubicin—ovarian cancer	0.000515	0.000525	CcSEcCtD
Degarelix—Pruritus—Epirubicin—ovarian cancer	0.000508	0.000518	CcSEcCtD
Degarelix—Diarrhoea—Epirubicin—ovarian cancer	0.000491	0.000501	CcSEcCtD
Degarelix—Hypersensitivity—Doxorubicin—ovarian cancer	0.00049	0.000499	CcSEcCtD
Degarelix—Asthenia—Doxorubicin—ovarian cancer	0.000477	0.000486	CcSEcCtD
Degarelix—Dizziness—Epirubicin—ovarian cancer	0.000475	0.000484	CcSEcCtD
Degarelix—Pruritus—Doxorubicin—ovarian cancer	0.00047	0.000479	CcSEcCtD
Degarelix—Vomiting—Epirubicin—ovarian cancer	0.000457	0.000466	CcSEcCtD
Degarelix—Diarrhoea—Doxorubicin—ovarian cancer	0.000455	0.000464	CcSEcCtD
Degarelix—Rash—Epirubicin—ovarian cancer	0.000453	0.000462	CcSEcCtD
Degarelix—Dermatitis—Epirubicin—ovarian cancer	0.000452	0.000461	CcSEcCtD
Degarelix—Headache—Epirubicin—ovarian cancer	0.00045	0.000459	CcSEcCtD
Degarelix—Dizziness—Doxorubicin—ovarian cancer	0.000439	0.000448	CcSEcCtD
Degarelix—Nausea—Epirubicin—ovarian cancer	0.000427	0.000435	CcSEcCtD
Degarelix—Vomiting—Doxorubicin—ovarian cancer	0.000423	0.000431	CcSEcCtD
Degarelix—Rash—Doxorubicin—ovarian cancer	0.000419	0.000427	CcSEcCtD
Degarelix—Dermatitis—Doxorubicin—ovarian cancer	0.000419	0.000427	CcSEcCtD
Degarelix—Headache—Doxorubicin—ovarian cancer	0.000416	0.000425	CcSEcCtD
Degarelix—Nausea—Doxorubicin—ovarian cancer	0.000395	0.000403	CcSEcCtD
